Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report. - Munarriz D; López-Godino O; Martinez-Cibrian N; Albiol N; Brillembourg H; Navarro-Velázquez S; Español-Rego M; Casanueva S; García-Tomás L; Muñoz-Sanchez G; Alserawan L; Benitez-Ribas D; et al. (International journal of molecular sciences, 2025)